Ling Huw
Impact in
- Cancer Research top 10%
- Immunology top 10%
- interferon and immune responses
- Galectins and Cancer Biology
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 2
- Gene expression and cancer classification 1
-
- Prostate Cancer Treatment and Research 1
- Ferroptosis and cancer prognosis 1
- Lung Cancer Treatments and Mutations 1
- Co-authors
- Lukas C. Amler (4 shared papers)Thomas Januario (1 shared paper)Sharon Yee (1 shared paper)David A. Lawrence (1 shared paper)Klaus W. Wagner (1 shared paper)Elizabeth A. Punnoose (1 shared paper)Avi Ashkenazi (1 shared paper)Guy Cavet (1 shared paper)
- Journals
- Clinical Cancer Research (3 papers)Journal of Clinical Oncology (3 papers)Nature Medicine (1 paper)Breast Cancer Research and Treatment (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Ling Huw
8 papers receiving 810 citations
Peers
Comparison fields: 5 of 62
- Cancer Research 142
- Immunology 196
- Molecular Biology 606
- Oncology 200
- Pulmonary and Respiratory Medicine 131
Countries citing papers authored by Ling Huw
This map shows the geographic impact of Ling Huw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Huw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Huw more than expected).
Fields of papers citing papers by Ling Huw
This network shows the impact of papers produced by Ling Huw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Huw. The network helps show where Ling Huw may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Huw, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 491 | |
| 2 | 2012 | 151 | |
| 3 | 2012 | 66 | |
| 4 | 2016 | 56 | |
| 5 | 2019 | 40 | |
| 6 | 2014 | 21 | |
| 7 | 2019 | 2 | |
| 8 | 2016 | 1 | |
| 9 | 2015 | 0 |
About Ling Huw
Ling Huw is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Genetics, Oncology and Artificial Intelligence, having authored 9 papers that have together received 828 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (2 papers), Chronic Lymphocytic Leukemia Research (1 paper), Prostate Cancer Treatment and Research (1 paper), Ferroptosis and cancer prognosis (1 paper), Lung Cancer Treatments and Mutations (1 paper), Gene expression and cancer classification (1 paper), Cancer Immunotherapy and Biomarkers (1 paper) and Phagocytosis and Immune Regulation (1 paper). The work is most often cited by research in Cancer Research (142 citations), Immunology (196 citations), Molecular Biology (606 citations), Oncology (200 citations) and Pulmonary and Respiratory Medicine (131 citations). Ling Huw has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Lukas C. Amler, Thomas Januario, Sharon Yee, David A. Lawrence, Klaus W. Wagner, Elizabeth A. Punnoose, Avi Ashkenazi, Guy Cavet, Robert Pitti and S.G. Hymowitz. Their work appears in journals such as Clinical Cancer Research, Journal of Clinical Oncology, Nature Medicine, Breast Cancer Research and Treatment and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.